Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Valsartan

Medicines register · Ireland

Valsartan — medicines in Ireland

101 authorised products containing Valsartan, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Dafiro HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/574/25-36

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Diovan 160 mg film-coated tablets PA0896/009/002

Valsartan

Novartis Ireland Limited

Marketed

Diovan 160 mg film-coated tablets PPA0465/461/001

Valsartan

PCO Manufacturing Ltd.

—

Diovan 160 mg film-coated tablets PPA1463/228/002

Valsartan

IMED Healthcare Ltd.,

—

Diovan 320 mg film-coated tablets PA0896/009/004

Valsartan

Novartis Ireland Limited

Marketed

Diovan 3mg/ml oral solution PA0896/009/005

Valsartan

Novartis Ireland Limited

Marketed

Diovan 40 mg film-coated tablets PA0896/009/003

Valsartan

Novartis Ireland Limited

Marketed

Diovan 80 mg film-coated tablets PA0896/009/001

Valsartan

Novartis Ireland Limited

Marketed

Diovan 80 mg film-coated tablets PPA0465/461/002

Valsartan

PCO Manufacturing Ltd.

—

Diovan 80 mg film-coated tablets PPA1463/228/001

Valsartan

IMED Healthcare Ltd.,

—

Entresto 6 mg/6 mg granules in capsules for opening EU/1/15/1058/023

Sacubitril, Valsartan

Novartis Europharm Limited

—

Exforge 10 mg/160 mg film-coated tablets EU/1/06/370/017-024

Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Exforge 5 mg/160 mg film-coated tablets EU/1/06/370/009-016

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Exforge 5 mg/80 mg film-coated tablets EU/1/06/370/001-008

Amlodipine besilate, Valsartan

Novartis Europharm Limited

—

Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets EU/1/09/569/13-24

Hydrochlorothiazide, Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Exforge HCT 10 mg/160 mg/25 mg film-coated tablets EU/1/09/569/37-48

Hydrochlorothiazide, Valsartan, Amlodipine besilate

Novartis Europharm Limited

—

Exforge HCT 10 mg/320 mg/25 mg film-coated tablets EU/1/09/569/49-60

Valsartan, Hydrochlorothiazide, Amlodipine besilate

Novartis Europharm Limited

—

Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets EU/1/09/569/1-12

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Exforge HCT 5 mg/160 mg/25 mg film-coated tablets EU/1/09/569/25-36

Amlodipine besilate, Hydrochlorothiazide, Valsartan

Novartis Europharm Limited

—

Neparvis 15 mg/16 mg granules in capsules for opening EU/1/16/1103/019

Sacubitril, Valsartan

Novartis Europharm Limited

—

Neparvis 6 mg/6 mg granules in capsules for opening EU/1/16/1103/018

Sacubitril, Valsartan

Novartis Europharm Limited

—

Valsartan Krka 160 mg film-coated tablets PA1347/010/008

Valsartan

KRKA, d.d., Novo mesto

Marketed

Valsartan Krka 320 mg film-coated tablets PA1347/010/009

Valsartan

KRKA, d.d., Novo mesto

Not marketed

Valsartan Krka 40 mg film-coated tablets PA1347/010/006

Valsartan

KRKA, d.d., Novo mesto

Marketed

Valsartan Krka 80 mg film-coated tablets PA1347/010/007

Valsartan

KRKA, d.d., Novo mesto

Marketed

Valsartan Rowa 160 mg film-coated tablets PA0074/083/003

Valsartan

Rowa Pharmaceuticals Limited

Not marketed

Valsartan Rowa 320 mg film-coated tablets PA0074/083/004

Valsartan

Rowa Pharmaceuticals Limited

Not marketed

Valsartan Rowa 40 mg film-coated tablets PA0074/083/001

Valsartan

Rowa Pharmaceuticals Limited

Not marketed

Valsartan Rowa 80 mg film-coated tablets PA0074/083/002

Valsartan

Rowa Pharmaceuticals Limited

Not marketed

Valsartan Teva 160 mg Film-coated Tablets PA0749/084/003

Valsartan

Teva Pharma B.V.

Marketed

Valsartan Teva 40 mg Film-coated Tablets PA0749/084/001

Valsartan

Teva Pharma B.V.

Not marketed

Valsartan Teva 80 mg Film-coated Tablets PA0749/084/002

Valsartan

Teva Pharma B.V.

Marketed

Valsartan Viatris 160 mg Film-coated Tablets PA23266/006/003

Valsartan

Viatris Limited

Marketed

Valsartan Viatris 320 mg Film-coated Tablets PA23266/006/004

Valsartan

Viatris Limited

Marketed

Valsartan Viatris 40 mg Film-coated Tablets PA23266/006/001

Valsartan

Viatris Limited

Marketed

Valsartan Viatris 80 mg Film-coated Tablets PA23266/006/002

Valsartan

Viatris Limited

Marketed

Valsartan/hydrochlorothiazide Krka 160 mg/12.5 mg film-coated tablets PA1347/004/002

Valsartan, Hydrochlorothiazide

KRKA, d.d., Novo mesto

Marketed

Valsartan/hydrochlorothiazide Krka 160 mg/25 mg film-coated tablets PA1347/004/003

Valsartan, Hydrochlorothiazide

KRKA, d.d., Novo mesto

Marketed

Valsartan/hydrochlorothiazide Krka 320 mg/12.5 mg film-coated tablets PA1347/004/004

Valsartan, Hydrochlorothiazide

KRKA, d.d., Novo mesto

Marketed

Valsartan/hydrochlorothiazide Krka 320 mg/25 mg film-coated tablets PA1347/004/005

Valsartan, Hydrochlorothiazide

KRKA, d.d., Novo mesto

Marketed

Valsartan/hydrochlorothiazide Krka 80 mg/12.5 mg Film-coated Tablets PA1347/004/001

Hydrochlorothiazide, Valsartan

KRKA, d.d., Novo mesto

Marketed

Valsartan/Hydrochlorothiazide Teva 160 mg/12.5 mg Film-coated Tablets PA0749/047/003

Valsartan, Hydrochlorothiazide

Teva Pharma B.V.

Marketed

Valsartan/Hydrochlorothiazide Teva 160 mg/25 mg Film-coated tablets PA0749/047/002

Valsartan, Hydrochlorothiazide

Teva Pharma B.V.

Marketed

Valsartan/Hydrochlorothiazide Teva 80 mg/12.5 mg Film-coated tablets PA0749/047/001

Valsartan, Hydrochlorothiazide

Teva Pharma B.V.

Marketed

Valtan 160 mg film-coated tablets PA0126/211/003

Valsartan

Clonmel Healthcare Ltd

Marketed

Valtan 40 mg film-coated tablets PA0126/211/001

Valsartan

Clonmel Healthcare Ltd

Marketed

Valtan 80 mg film-coated tablets PA0126/211/002

Valsartan

Clonmel Healthcare Ltd

Marketed

Valtan Comp 80mg/12.5mg Film-coated tablets PA0126/216/001

Valsartan, Hydrochlorothiazide

Clonmel Healthcare Ltd

Marketed

Vatan 160 mg Film-coated Tablets PA0711/183/003

Valsartan

Marketed

Vatan 40 mg Film-coated Tablets PA0711/183/001

Valsartan

Marketed

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/substance/valsartan

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.